Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12564/490
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGajewska, Małgorzata-
dc.contributor.authorRutkowska, Elżbieta-
dc.contributor.authorKwiecień, Iwona-
dc.contributor.authorRzepecki, Piotr-
dc.contributor.authorSułek, Kazimierz-
dc.date.accessioned2022-12-23T07:38:56Z-
dc.date.available2022-12-23T07:38:56Z-
dc.date.issued2022-
dc.identifier.citationLekarz Wojskowypl
dc.identifier.issn0024-0745-
dc.identifier.urihttp://hdl.handle.net/20.500.12564/490-
dc.descriptionLicencja CC-BY-NC-SApl
dc.description.abstractThe analysis of the AgNORs was performed in patients with acute myeloid leukemia (AML) to verify the role of AgNOR parameters in predicting complete remission (CR). Bone marrow aspirates from 24 patients with AML were stained with silver nitrate and underwent morphological, immuophenotypic, and genetic assessment. The mean AgNORs number, mean AgNORs area, and the mean AgNOR area-to-nucleus-area ratio were calculated for each case. After induction therapy, patients who achieved complete remission (CR) received intensive consolidation treatment. Fifteen patients underwent allogenic bone marrow transplantation. A higher mean AgNOR area-to-nucleus-area ratio was found in group with the CR status.pl
dc.language.isoenpl
dc.relation.ispartofseries2022;100(3):177–180;10.53301/lw/151583-
dc.subjectacute myeloid leukemiapl
dc.subjectargyrophilic nucleolar organizer regionspl
dc.subjectcomplete remissionpl
dc.titleCan AgNOR counts and configuration predict complete remission in adult acute myelogenous leukemia patients?pl
dc.typeinfo:eu-repo/semantics/articlepl
Appears in Collections:2022 rok

Files in This Item:
File Description SizeFormat 
Can AgNOR counts and.pdf888.88 kBAdobe PDFThumbnail
View/Open
Show simple item record



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.